Evan Bander, MD is a neurosurgeon-scientist training at New York Presbyterian/Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center (MSK). Dr. Bander received a bachelor’s degree in biological sciences and graduated Magna Cum Laude from Cornell University in 2011. He received his M.D. from Weill Cornell Medical College in 2016, where he won the Sidney and Viola Borkon Memorial Prize as well as the John Metcalf Polk Prize which is “the highest scholastic honors a student can achieve at the medical school”. He was also selected for membership in the Alpha Omega Alpha Honor Medical Society. He is currently a 5th year neurosurgery resident and has been conducting a post-doctoral research fellowship, under the mentorship of Dr. Viviane Tabar, investigating the intersection of tumor genetics and the immune microenvironment in gliomas. His work has been awarded the Christopher G. Gaposchkin Resident Research Award for Distinction in Scientific Inquiry in Neurological Surgery at Weill Cornell.
Dr. Bander has an extensive research experience. He was previously awarded a Howard Hughes Medical Institute Research Fellowship investigating the perivascular niche of gliomas under the guidance of Dr. Shahin Rafii at the Ansary Stem Cell Institute. Prior to that, he worked with Dr. Chris Schaffer in the Cornell University Department of Biomedical Engineering, publishing on the role of micro-vessel occlusions in Alzheimer’s disease. He has also published research with Dr. David Scheinberg at MSK on the use of carbon nanotubes as scaffolds for novel cancer therapeutics.
